These effects, together with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 assist the notion of targeting ACKR3 as a unique approach to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. Disclaimer: The above is usually a https://carlw691zvr1.frewwebs.com/profile